VIPER is at the intersection of precision diagnosis and care coordination. 

  • Automate the screening process from remote patient identification to qualified enrollment
  • Learn how lab-agnostic genomic data ingestion is automating the matching of patients to precision trials 
  • Aggregate site and study level patient data to hit your study KPIs

I am encouraged that Deep Lens has developed a promising solution to tackle some of the underlying obstacles that are challenging to our sites

James Langford
Vice President of Clinical Operations, AIVITA Biomedical

Deep Lens’ VIPER can facilitate greater patient access to cutting-edge treatments.
By identifying eligible patients for clinical trials based on their digital and molecular biomarkers, VIPER is exactly what is needed to boost trial enrollment numbers. Patients deserve access to the most promising treatments and getting access should not be a burden.

David R. Braxton, M.D.
Molecular Genetic Pathologist
Copyright © 2020 Deep Lens, Inc. All rights reserved.